Lipid regulation of group 2 innate lymphoid cell function: Moving beyond epithelial cytokines - 04/05/18
Doi : 10.1016/j.jaci.2018.02.034
Taylor A. Doherty, MD, David H. Broide, MB, ChB ⁎ 
Department of Medicine, University of California, San Diego, San Diego, Calif
∗Corresponding author: David H. Broide, MB, ChB, Department of Medicine, University of California, San Diego, Biomedical Sciences Building, Rm 5090, 9500 Gilman Dr, La Jolla, CA 92093-0635.Department of MedicineUniversity of California, San DiegoBiomedical Sciences BuildingRm 5090, 9500 Gilman DrLa JollaCA92093-0635
Key words : Group 2 innate lymphoid cells, prostaglandin E2, cysteinyl leukotriene, prostaglandin D, eicosanoid, asthma, aspirin-exacerbated respiratory disease
Le texte complet de cet article est disponible en PDF.
| Supported by National Institutes of Health (NIH) grants AI 114585 and AI 70535 (to T.A.D.) and NIH grants AI 107779, AI 38425, AI 70535, and AI 72115 (to D.H.B.). |
|
| Disclosure of potential conflict of interest: T. A. Doherty and D. H. Broide have received grants from the National Institutes of Health. |
© 2018
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 141 - N° 5
P. 1587-1589 - mai 2018 Retour au numéro
Article précédent
- The complement system in the airway epithelium: An overlooked host defense mechanism and therapeutic target?
- Hrishikesh S. Kulkarni, M. Kathryn Liszewski, Steven L. Brody, John P. Atkinson
- More than a decade follow-up in patients with severe or difficult-to-treat asthma: The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) II
- Bradley E. Chipps, Tmirah Haselkorn, Brandee Paknis, Benjamin Ortiz, Eugene R. Bleecker, Farid Kianifard, Aimee J. Foreman, Stanley J. Szefler, Robert S. Zeiger, Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens Study Group
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?